Jazz Pharmaceuticals CEO Renee Gala Sells 3,967 Shares via 10b5-1 Plan & Tax Withholding
Jazz Pharmaceuticals plc
Subscribe to track JAZZ
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Insider Transaction Alert: Jazz Pharmaceuticals plc ($JAZZ) Insider: Renee D. Gala (President & CEO) Transaction Date: September 8, 2026 Action: Disposition of 3,967 Ordinary Shares
- Tax Withholding (Code F): 1,967 shares @ $246.81 ($485,475.27)
- Rule 10b5-1 Sale (Code S): 2,000 shares @ $243.03 ($486,060.00) Total Transaction Value: $971,535.27 Post-Transaction Ownership: 143,394 shares (Direct) Significance: Low (Routine 10b5-1 plan executed alongside standard RSU tax withholding)
Comprehensive Analysis
Executive Summary
On September 10, 2026, Jazz Pharmaceuticals plc ($JAZZ) filed a Form 4 disclosing dispositions of Ordinary Shares by President and Chief Executive Officer Renee D. Gala on September 8, 2026. The filing reports two separate transactions totaling 3,967 shares disposed for an aggregate value of approximately $971,535.27.
Transaction Breakdown
-
Tax Withholding (Code F):
- Shares Disposed: 1,967 shares
- Price Per Share: $246.81
- Value: $485,475.27
- Description: Shares withheld to satisfy tax liabilities associated with the vesting of restricted stock units (RSUs).
-
Open Market Sale (Code S):
- Shares Sold: 2,000 shares
- Price Per Share: $243.03
- Value: $486,060.00
- Description: Executed automatically pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on June 4, 2026.
Ownership Impact & Market Context
- Pre-Transaction Holdings: 147,361 shares
- Post-Transaction Holdings: 143,394 shares
- Percentage Reduction: ~2.69% of direct holdings
- Trading Significance: Low. The transactions represent non-discretionary events consisting of standard tax withholding on equity compensation vesting and an automatic sale under a pre-established Rule 10b5-1 trading plan.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.